Epidermal growth factor receptor (EGFR), one of the most characterized receptor tyrosine kinases (RTKs), regulates many cellular functions, including survival, proliferation, and differentiation. The aberrant activation of EGFR by overexpression or activating mutations is a major mechanism underlying the pathogenesis of human cancers, including colorectal and lung cancers, and participates in acquired resistance to anti-cancer agents (1-4).Ligand-bound EGFR proteins form an asymmetric homodimer on the plasma membrane, which is followed by the activation of its tyrosine kinase. Activated EGFR is then rapidly internalized via clathrin-mediated endocytosis and clathrin-independent endocytosis. Sequential sorting to several vesicular transport systems, including early endosomes, late endosomes, multivesicular bodies (MVBs), and recycling endosomes, http://www.jbc.org/cgi